GlaxoSmithkline Consumer Healthcare (Delisted) share price history
BSE: 500676
Last traded ₹10,732.60 on 15 Apr 2020
Delisted on 24 Jun 2021.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
Apr 2020
8 Apr · Suspension of Trading
Members of the Exchange are hereby informed that the trading in Equity Shares of GlaxoSmithKline Consumer Healthcare Limited shall be suspended w.e.f. April 16, 2020 (i.e. closing hours of trading on April 15, 2020) on account of Scheme of Amalgamation with Hindustan Unilever Limited.
Mar 2020
13 Mar · Business
Feb 2020
Results
Standalone; ₹ crore, the charts by years to December, then March, the table by quarter. No standalone results on record for the year to Mar 2014.Quarterly results
Quarter to Dec 2019, against the quarter beforeFiled 6 Feb
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1,159 Crdown 13.85%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹277 Crdown 19.89%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- 23.9%
Revenue by year
Net profit by year, a loss in red
The company moved its year end from December to March: its last year to December on record ended in Dec 2012, its first year to March in Mar 2015.
| ₹ crore | Mar 2018 | Jun 2018Filed 8 Aug | Sep 2018Filed 1 Nov | Dec 2018Filed 14 Feb | Mar 2019Filed 10 May | Jun 2019Filed 2 Aug | Sep 2019Filed 7 Nov | Dec 2019Filed 6 Feb |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,180 | 1,107 | 1,272 | 1,117 | 1,286 | 1,194 | 1,345 | 1,159 |
| Net profit | 212 | 200 | 275 | 221 | 286 | 248 | 345 | 277 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 18.0% | 18.1% | 21.7% | 19.8% | 22.2% | 20.8% | 25.7% | 23.9% |
Business segments
In the year to Mar 2019 the company reports one business segment, Nutrition, which carries all its revenue.
Where the return came from
Yearly rates to Mar 2019, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +18.8% | +40.4% | −15.4% | 0.0% |
| 3 years | +6.3% | – | – | 0.0% |
| 5 years | +11.0% | – | – | 0.0% |
GlaxoSmithkline Consumer Healthcare share price by year
Each calendar year to 2020.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2020 | 10,732.60 | +29.2% | 10,732.60 | 8,008.90 |
| 2019 | 8,308.90 | +8.7% | 9,256.20 | 6,924.30 |
| 2018 | 7,645.25 | +16.9% | 7,807.50 | 5,842.40 |
| 2017 | 6,538.00 | +30.7% | 6,599.25 | 4,909.05 |
| 2016 | 5,003.35 | −21.9% | 6,675.70 | 4,901.75 |
| 2015 | 6,406.20 | +9.2% | 6,787.05 | 5,598.20 |
Recent sessions
The last 10 trading days to 15 Apr 2020, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 15 Apr 2020 | 10,310.00 | 10,850.00 | 10,310.00 | 10,732.60 | 10,667.14 | 1,99,724 |
| 13 Apr 2020 | 10,450.00 | 10,566.40 | 10,120.00 | 10,236.30 | 10,231.56 | 41,955 |
| 9 Apr 2020 | 10,878.00 | 10,878.00 | 10,141.15 | 10,356.05 | 10,366.68 | 53,417 |
| 8 Apr 2020 | 10,590.00 | 11,296.30 | 10,504.55 | 10,639.30 | 10,946.28 | 97,773 |
| 7 Apr 2020 | 9,660.00 | 10,700.00 | 9,660.00 | 10,593.40 | 10,220.58 | 87,649 |
| 3 Apr 2020 | 9,600.00 | 9,773.75 | 9,270.00 | 9,356.20 | 9,418.29 | 77,269 |
| 1 Apr 2020 | 10,029.00 | 10,084.30 | 9,420.55 | 9,548.55 | 9,650.30 | 53,600 |
| 31 Mar 2020 | 9,600.00 | 10,020.00 | 9,461.50 | 9,974.25 | 9,817.62 | 23,989 |
| 30 Mar 2020 | 9,300.00 | 9,522.50 | 9,163.85 | 9,449.90 | 9,385.21 | 52,255 |
| 27 Mar 2020 | 9,845.00 | 9,854.25 | 9,223.00 | 9,374.85 | 9,466.22 | 38,730 |
Company details
- Legal name
- GlaxoSmithkline Consumer Healthcare Ltd.
- BSE code
- 500676
- ISIN
- INE264A01014
- Listed
- Apr 1979
- Face value
- ₹10
- Former symbols
- GSKCONS, SMITKLBECH
- CIN
- L24231PB1958PLC002257
- Corporate identity number, the registrar of companies' code for it